Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer

Chinese Journal of Pathology

Volumn 37, Issue 8, 2008, Pages 529-535

  Liu, Fang Fang ^a   Wei, Jia ^a   Lang, Rong Gang ^a   Fan, Yu ^a   Cui, Li Fang ^a   Gu, Feng ^a   Fu, Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; Chemokinese, CXC; Neoplasm metastasis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; BREAST CANCER; CANCER INVASION; CANCER STAGING; CLINICAL FEATURE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; LYMPH VESSEL; PROTEIN EXPRESSION; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOKINE CXCL12; CHEMOKINES, CXC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, CXCR4;

EID: 53649108403     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tavassoli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003:10.
2. Guo XJ, Chen L, Lang RG, et al. Invasive micropapillary carcinoma of the breast-association of pathologic features with lymph node metastasis. Am J Clin Pathol, 2006,126(5):740-746.
3. Salvucci O, Bouchard A, Baccarelli A, et al. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat, 2006,97(3):275-283.
4. Zou W, Machelon V, Coulomb-L'Hermin A, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med, 2001,7(12):1339-1346.
5. Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res, 2002,62(24):7203-7206.
6. Kang H, Watkins G, Parr C, et al. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res, 2005,7(4):R402-R410.
7. Barbero S, Bonavia R, Bajetto A, et al. Stromal cell-derived factor 1 alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res, 2003,63(8):1969-1974.
8. Koshiba T, Hosotani R, Miyamoto Y, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res, 2000,6(9):3530-3535.
9. Singh S, Singh UP, Grizzle WE, et al. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest, 2004, 84(12):1666-1676.
10. Middleton J, Neil S, Wintle J, et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell, 1997,91(3):385-395.
11. Tarasova NI, Stauber RH, Michejda CJ. Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4. J Biol Chem, 1998,273(26):15883-15886.
12. Hartmann TN, Burger JA, Glodek A, et al. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene, 2005,24(27):4462-4471.
13. Marchesi F, Monti P, Leone BE, et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res, 2004,64(22):8420-8427.
14. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001,410(6824):50-56.
15. Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res, 2004,64(12):4302- 4308.
16. Liang Z, Yoon YH, Votaw J, et al. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res, 2005,65(3):967-971.
17. Amara A, Lorthioir O, Valenzuela A, et al. Stromal cell-derived factor-1 alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem, 1999,274(34):23916-23925.
18. De La Luz Sierra M, Yang F, Narazaki M, et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood, 2004,103(7):2452-2459.
19. Campbell JJ, Hedrick J, Zlotnik A, et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science, 1998,279(5349):381-384.
20. Shamri R, Grabovsky V, Gauguet JM, et al. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol, 2005,6(5):497-506.
21. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res, 2004,64(22):8451-8455.
22. Vermi W, Bonecchi R, Facchetti F, et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol, 2003,200(2):255-268.
23. Hall JM, Korach KS. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol, 2003,17(5):792-803.
24. Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell, 2004,6(5):459-469.
25. Cabioglu N, Yazici MS, Arun B, et al. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res, 2005,11(16):5686-5693.